Previous 10 | Next 10 |
We are constantly researching winning stocks with insider activity. Insider activity (officers and directors of the firm) is informative as they are able to outperform the market on average. This is explained by their superior insider information and/or superior value investing capabilities. ...
Futures contracts tied to the major U.S. stock indexes rose early Thursday as investors awaited two closely watched jobs reports on the week's final day of trading ahead of the July Fourth holiday. Futures for Dow Jones Industrials bounced 255 points, or 1%, early Thursday, to 25,830. ...
As of June 30, the daily number of new cases of COVID-19 in the U.S. has skyrocketed to more than 46,000. Since the pandemic was declared in mid-March, the cumulative number of cases in the nation has surpassed 2.7 million, and over 130,000 Americans have died. Unfortunately, the curve is anyth...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . U.S. stock indexes futures rose as much as 1% overnight as investors look ahead to two jobs reports for clarity on the economic ...
The recession Our current recession is masked by this historic climb in stock prices that feels like a new bull market but appears to be a classic, bear market rally. Jeff Miller : "I remain bearish. ... Recession odds are 100%. ... Stock market strength has provided a false sense of s...
Shares of Pfizer (NYSE: PFE) rose 3.2% on Wednesday after the pharmaceutical giant released promising early results from its COVID-19 vaccine trials. Pfizer is working with German biotech BioNTech (NASDAQ: BNTX) to develop a novel coronavirus vaccine. On Wednesday, the...
Dynavax (NASDAQ: DVAX) shares were trading 6.5% lower as of 3:35 p.m. EDT on Wednesday after competitor Pfizer (NYSE: PFE) reported data showing its vaccine produces a significantly larger number of antibodies than are found in recovered COVID-19 patients. Dynavax is collaborati...
In an early-stage phase 1/2 clinical trial, BNT162b1, the COVID-19 vaccine being developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) , produced antibodies against SARS-CoV-2, the novel coronavirus that causes COVID-19, after two doses. Seven days after the second dose at the lowe...
Shares of Moderna (NASDAQ: MRNA) were sliding 6.2% lower as of 11:41 a.m. EDT on Wednesday. Two factors appeared to be behind the biotech stock's decline. First, the FDA issued an update on Tuesday that could mean no COVID-19 vaccine will be approved until next year. Second, Pfizer (NYSE:...
Pfizer ( PFE +3.7% ) and development partner BioNTech SE ( BNTX +3.4% ) announce preliminary results from an ongoing Phase 1/2 clinical trial evaluating the safety, tolerability and immunogenicity of escalating doses of BNT162b1, the most advanced of their four investigational COVID-...
News, Short Squeeze, Breakout and More Instantly...
2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...
2024-05-04 06:45:00 ET Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk . Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling and Novo's shares more than tripling over the last three ye...
Pfizer Inc (NYSE:PFE) reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That’s down 33% year-over-year, beating the ...